[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359378-105":59,"doc-detail-359378-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","serotonin-modulates-lineage-plasticity-in-neuroendocrine-prostate-cancer-via-epigenetic-reprogramming-research-article","Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming - Research Article","","Neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant subtype marked by lineage plasticity and poor prognosis. This study identifies a tumor-intrinsic serotonin axis that drives NEPC commitment and progression by promoting histone serotonylation and reprogramming H3K4me3 chromatin and downstream gene expression. Elevated intracellular serotonin suppresses androgen receptor signaling during NE differentiation. Pharmacologic inhibition of serotonin synthesis with the DDC inhibitor carbidopa impairs tumor growth and extends survival in multiple xenograft models, highlighting histone serotonylation as a druggable vulnerability.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/serotonin-modulates-lineage-plasticity-in-neuroendocrine-prostate-cancer-via-epigenetic-reprogramming-research-article/359378/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/serotonin-modulates-lineage-plasticity-in-neuroendocrine-prostate-cancer-via-epigenetic-reprogramming-research-article/359378.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does serotonin play in neuroendocrine prostate cancer (NEPC)?","Question",{"text":112,"@type":113},"The document states that NEPC produces and accumulates serotonin, creating a tumor-intrinsic serotonin axis that promotes NEPC lineage commitment and progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does intracellular serotonin influence NEPC cell fate at the epigenetic level?",{"text":117,"@type":113},"High intracellular serotonin promotes histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and altering downstream gene expression that drives NE differentiation.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic strategy is tested, and what is the outcome?",{"text":121,"@type":113},"The study uses carbidopa to inhibit serotonin synthesis via DDC. It significantly impairs tumor growth and prolongs survival in genetically engineered and patient-derived xenograft models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359378,1790335308,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ReseaRch aRticle  \nSerotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic  \nReprogramming   \nYiyi Ji1,2, Cheng-Wei Ju3, Lei Chen4, Kai Shen1, Ruopeng Su1, Ang Li1, Xinyu Liu1, Bo Liu1, Xinran Zhang5, Ruitu Lyu2, Peng Xia2,6, Han Li2, Yiqian Pan2,7, Yunzheng Liu8, Man HinTse9,10, Yizheng Xue1,11, Hongyang Qian1,12, Na Jing12, Helen He Zhu13, Liangliang Wang14, Li-Sheng Zhang9,10, Shu-Heng Jiang15, Weiwei Zhang1, Liang Dong1, Zejun Yan4, Jiahua Pan1, Yinjie Zhu1, Jiangbo Wei5,16, Qi Wang1,17, and Wei Xue1  \nNeuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant  \nsubtype of prostate cancer characterized by lineage plasticity. Although metabolic and signaling molecules are increasingly recognized as modulators of tumor progression, their role in cell fate transition remains unclear. NE (neuroendocrine) tumors produce and accumulate serotonin, a neurotransmitter that regulates diverse physiologic processes. In this study, we identify a tumor-intrinsic serotonin axis as a key driver of NEPC lineage commitment and progression. NEPC endogenously synthesizes serotonin via aromatic L-amino acid decarboxylase (AADC; encoded by DDC) and reuptakes it through the transporter SLC6A4 . Mechanistically, high levels of intracellular serotonin promote histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and downstream gene expression, which drives NE differentiation and is associated with suppressed androgen receptor signaling. Pharmacologic inhibition of serotonin synthesis using the FDA-approved DDC inhibitor carbidopa significantly impairs tumor growth and prolongs survival in both genetically engineered and patient-derived xenograft models, highlighting histone serotonylationas a druggable vulnerability in NEPC.  \nSigNifiCaNCE: Collectively, our findings uncover an epigenetically embedded, serotonin-driven lineage program in NEPC, coupling tumor-intrinsic serotonin metabolism with tumor cell fate control, and identify histone serotonylation as a tractable therapeutic vulnerability in lineage-plastic prostate cancer.  \nintRoduction  \nNeuroendocrine (NE) prostate cancer (NEPC) represents a highly aggressive and therapy-resistant subtype of prostate cancer, characterized by lineage plasticity and poor prognosis. NEPC often arises following inhibition of the androgen receptor (AR) pathway (1–3), wherein AR-dependent adenocarcinomas transition to an AR-independent NE state (4, 5) . This lineage reprogramming process involves the transdifferentiation of prostate epithelial cells into NE-like cells, marked by the silencing of AR signaling and the activation of NE lineage–defining factors such as SOX2 (6), SOX9 (7), ASCL1 (8–10), and EZH2 (11–13) . Upstream amplification of MYCN  \n1Department of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2Department of Chemistry, The University of Chicago, Chicago, Illinois. 3Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois. 4Department of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, China. 5Department of Chemistry, National University of Singapore, Singapore, Singapore. 6Zhongnan Hospital of Wuhan University, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.  \n7Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, China. 8Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California. 9Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong, Hong Kong SAR, China. 10Department of Chemistry, The Hong Kong University of Science and Technology, Hong Kong, Hong Kong SAR, China. 11Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania.  \n12Department of Pathology,","cbCaid7IIQ21SbVU","https://ap.wps.com/l/cbCaid7IIQ21SbVU","pdf",20358010,21,"English","# Introduction\n## Neuroendocrine prostate cancer and lineage plasticity\n## Serotonin as a modulator of cancer biology\n# Results (from abstract summary)\n## Tumor-intrinsic serotonin synthesis and reuptake\n## Histone serotonylation and H3K4me3 reprogramming\n## Therapeutic inhibition with carbidopa","[{\"question\":\"What role does serotonin play in neuroendocrine prostate cancer (NEPC)?\",\"answer\":\"The document states that NEPC produces and accumulates serotonin, creating a tumor-intrinsic serotonin axis that promotes NEPC lineage commitment and progression.\"},{\"question\":\"How does intracellular serotonin influence NEPC cell fate at the epigenetic level?\",\"answer\":\"High intracellular serotonin promotes histone serotonylation at H3K4me3Q5, reconfiguring the H3K4me3 chromatin landscape and altering downstream gene expression that drives NE differentiation.\"},{\"question\":\"What therapeutic strategy is tested, and what is the outcome?\",\"answer\":\"The study uses carbidopa to inhibit serotonin synthesis via DDC. It significantly impairs tumor growth and prolongs survival in genetically engineered and patient-derived xenograft models.\"}]","Serotonin Modulates Lineage Plasticity in Neuroendocrine Prostate Cancer via Epigenetic Reprogramming - Research Article | PDF",1790136778,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64445bd725b802e0c5dbacf42951795d.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4c51048fcd89e6174d253d969156f42.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a87e56e7e387582d888ef8ed610e3d5a.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bdc41c0f20d6efd58fba164228cc4f8d.webp",980,1311]